Point-of-Care (POC) Infectious Disease Diagnostics Market, by Technology (Lateral Flow, Agglutination Assays, Flow-Through, and Solid Phase), By Application (HIV, Tropical Disease, Liver Disease, Inflammatory Disease, Respiratory Disease, Hospital Associated Infections (HAIs), Sexual Health Disorders, and Others), By End User (Hospitals, Diagnostic Laboratories, Home-Care Settings, and Others), and Region - Global Industry Insights, and Forecast till 2025

  • Published On : Apr 2018 |
  • Pages : 145 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Point of Care Infectious Disease Diagnostics Market - Insights

Point of care diagnosis involves testing of the samples at the point of care to facilitate rapid diagnosis and decide on the treatment plan accordingly. Infectious diseases often need to be diagnosed early, as they can turn lethal against immunity system. Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment. Advanced technologies used in point-of-care diagnostics such as lateral flow, agglutination assays, and solid phase are integrated with innovative features such as portability of handheld devices. The U.S. Food & Drug Administration (FDA) is responsible for overseeing all the activities associated with marketing of point of care diagnostic products. Along with FDA, the Clinical Laboratory Improvement Amendments (CLIA) also regulates these products. Point of care tests are efficient and save time and costs due to various benefits provided by it such as preventing sample spillage, no necessity of skilled professionals, as the tests can be performed easily, and low costs. Some of the commercially available point of care diagnostics include CoaguChek Pro II, Uni-Gold HIV, Accu-Chek Aviva meter, Alere I Influenza A & B, OneTouch Verio Flex, and ICON SC Strep A.

Advances in technology of point of care diagnostics is expected to support the growth of the point of care infectious disease diagnostics market

Centralized laboratory testing is the gold standard and has established in biochemistry, hematology, and diagnostics. Point-of-care diagnostic offers various advantages such as ease of use in remote areas, technological advancements, and lowered price points. Small handheld point-of-care devices are portable and can be used by patients themselves. These tests use fingerstick or capillary samples, which are directly applied to instrument and avoid need of sample containers. Technologies such as lateral flow, various molecular assays integrated with point-of-care have changed the outlook of point-of-care diagnostics. For instance, products offered by leading manufacturers such as Alere and Roche are immunoassays, which are cost-effective and provide rapid results. Furthermore, in 2014, Becton, Dickinson, and Company offered point-of-care system BD FACSPresto for HIV/AIDS. It offers percentage results of CD4 T lymphocytes and hemoglobin concentration. Moreover, Infectious Disease Research Institute (IDRI) developed a fusion antigen in January 2017, which is used as a part of diagnostic test manufactured by InBios International, Inc. for Chagas disease.

The global point of care infectious disease diagnostics market was valued at US$ 1,764.6 million in 2016 and is expected to witness a robust CAGR of 14.5% over the forecast period (2017 – 2025).

Figure 1. Global Point of Care Infectious Disease Diagnostics Market Share, by Technology (%) 2017 and 2025

POC Infectious Disease Diagnostics Market | Coherent Market Insights

Source: Coherent Market Insights Analysis (2017)

Initiatives and funding from individual organizations for point-of-care infectious disease diagnostics is expected to boost the market growth over the forecast period

Various organizations and governments are focused on research and development for infectious diseases to provide effective diagnostic and treatment options. For instance, QuantuMDx Group received funding from Bill & Melinda Gates Foundation to develop and test company’s CAPTURE-XT pathogen concentration technology and Q-POC molecular diagnostic platform for rapid low cost detection of tuberculosis in 2016. In January 2018, University of Glasgow-led project received US$ 1.85 million funding, which is a part of Global Challenges Research Fund (GCRF). This project will develop new tests for parasitic diseases and point-of-care testing in remote locations to help enable rapid diagnosis, and rapid treatment.

However, limitations associated with point-of-care testing such as specific steps and timing and different methodologies than laboratory testing, which may provide difference in the test results from laboratory testing may hinder the growth of the market. Moreover, in remote locations proper inventory system must be planned before to prevent deterioration, lack of stock, and shelf life issues which may further hinder growth of the market.

Major players operating in the point of care infectious disease diagnostics market include Danaher Corporation, Abbott Laboratories, Alcon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.

Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful.

Market Dynamics

Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.

Key features of the study:

  • This report provides in-depth analysis of point of care infectious disease diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global point of care infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global point of care infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care infectious disease diagnostics market

Detailed Segmentation:

  • Global Point of Care Infectious Disease Diagnostics Market, By Technology:
    • Lateral Flow
    • Agglutination Assays
    • Flow-Through
    • Solid Phase
  • Global Point of Care Infectious Disease Diagnostics Market, By Application:
    • HIV
    • Tropical Disease
    • Liver Disease
    • Inflammatory Disease
    • Respiratory Disease
    • Hospital Associated Infections (HAIs)
    • Sexual Health Disorders
    • Others
  • Global Point of Care Infectious Disease Diagnostics Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Home-Care Settings
    • Others
  • Global Point of Care Infectious Disease Diagnostics Market, By Geography:
    • North America
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
      • By Application:
        • HIV
        • Tropical Disease
        • Liver Disease
        • Inflammatory Disease
        • Respiratory Disease
        • Hospital Associated Infections (HAIs)
        • Sexual Health Disorders
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
      • By Application:
        • HIV
        • Tropical Disease
        • Liver Disease
        • Inflammatory Disease
        • Respiratory Disease
        • Hospital Associated Infections (HAIs)
        • Sexual Health Disorders
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
      • By Application:
        • HIV
        • Tropical Disease
        • Liver Disease
        • Inflammatory Disease
        • Respiratory Disease
        • Hospital Associated Infections (HAIs)
        • Sexual Health Disorders
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
      • By Application:
        • HIV
        • Tropical Disease
        • Liver Disease
        • Inflammatory Disease
        • Respiratory Disease
        • Hospital Associated Infections (HAIs)
        • Sexual Health Disorders
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
      • By Application:
        • HIV
        • Tropical Disease
        • Liver Disease
        • Inflammatory Disease
        • Respiratory Disease
        • Hospital Associated Infections (HAIs)
        • Sexual Health Disorders
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
      • By Application:
        • HIV
        • Tropical Disease
        • Liver Disease
        • Inflammatory Disease
        • Respiratory Disease
        • Hospital Associated Infections (HAIs)
        • Sexual Health Disorders
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Danaher Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Becton, Dickinson, and Company
    • Trinity Biotech Plc
    • AccuBioTech Co., Ltd.
    • Cardinal Health, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • PEST Analysis
  4. Global Point of Care Infectious Disease Diagnostics Market, By Technology, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Lateral Flow
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Agglutination Assays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Flow-Through
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Solid Phase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
  5. Global Point of Care Infectious Disease Diagnostics Market, By Application, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • HIV
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Tropical Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Liver Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Inflammatory Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Respiratory Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Hospital Associated Infections (HAIs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Sexual Health Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
  6. Global Point of Care Infectious Disease Diagnostics Market, By End User, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Home-Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
  7. Global Point of Care Infectious Disease Diagnostics Market, By Regions, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2016 – 2025
    • North America
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Acon Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Hoffman-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Becton, Dickinson, and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Trinity Biotech Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • AccuBioTech Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cardinal Health, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 40 market data tables and 42 figures on "Point of Care Infectious Disease Diagnostics Market - Global forecast to 2025”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.